European Journal of Cancer and Clinical Oncology
Volume 19, Issue 2, February 1983, Pages 203-208
On the receiving end—patient perception of the side-effects of cancer chemotherapy
References (9)
- et al.
Cancer chemotherapy—what have we achieved?
Lancet
(1980) - et al.
Evaluation of quality of life in patients receiving treatment for advanced breast cancer
Lancet
(1976) - et al.
Oral lorazepam to improve tolerance of cytotoxic chemotherapy
Lancet
(1981) - et al.
The utility of different health states as perceived by the general public
J Chronic Dis
(1978)
There are more references available in the full text version of this article.
Cited by (787)
Engineered Hyaluronic Acid-Based Smart Nanoconjugates for Enhanced Intracellular Drug Delivery
2023, Journal of Pharmaceutical SciencesNanorobots: An innovative approach for DNA-based cancer treatment
2023, Journal of Drug Delivery Science and TechnologyThe development of a novel antioxidant-based antiemetic drug to improve quality of life during anticancer therapy
2022, Biochemistry and Biophysics Reports7-hydroxycoumarin modulates Nrf2/HO-1 and microRNA-34a/SIRT1 signaling and prevents cisplatin-induced oxidative stress, inflammation, and kidney injury in rats
2022, Life SciencesCitation Excerpt :On the other hand, off-target organ toxicity is a well-known drawback and potentially fatal complication of classical chemotherapy usage. The side effects result in treatment regimens disruption and patient adherence incompliance [38,39]. Given the wide range of therapeutic effects of CIS [4] and the fact that its induced renal toxicity is the limiting factor in its clinical use, minimizing its associated renal intoxication is a key to maximize its clinical outcomes.
Copyright © 1983 Published by Elsevier Ltd.